About Carbios
CARBIOS is a biotechnology company that develops and industrializes biological solutions to redesign the life cycle of plastics and textiles. Inspired by nature, CARBIOS develops enzyme-based biological processes to degrade plastics with the aim of preventing plastic and textile pollution and accelerating the transition to a circular economy. Its two innovative technologies - for the biorecycling of PET and the biodegradation of PLA - are currently being scaled up to industrial and commercial levels. The industrial demonstration plant for biorecycling has been in operation since 2021, and construction of the world's first biorecycling plant is scheduled to resume before the end of 2025, provided the necessary additional funding can be secured. The company is supported by renowned brands from the cosmetics, food and apparel industries that want to improve the recyclability and circular economy of their products. Nestlé Waters, PepsiCo and Suntory Beverage & Food Europe are members of a packaging consortium founded by CARBIOS and L'Oréal. On, Patagonia, PUMA, PVH Corp. and Salomon are working with CARBIOS in a textile consortium. CARBIOS is part of the global community of B Corp™-certified companies that are transforming their business models for the common good.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
News about Carbios
Here you will find Carbios
Last viewed contents
Circular economy for plastics - Biotechnological solutions for degradation and recycling of plastics
Artificial intelligence is drastically changing the healthcare sector - Companies are engaging with AI and investing in it, but only 29 percent feel well prepared to use GenAI for competitive advantage
Malaria Parasites Move on Right-Handed Helices - Motion patterns help the transition between tissue compartments
Coriolis Pharma Research GmbH - Martinsried, Germany
Rentschler Biopharma SE - Laupheim, Germany
Novozymes Biopharma Signs License Agreement with GE Healthcare to Produce and Sell Protein A
Biotech has Positive Year Despite Weak Fourth Quarter Performance - Burrill looks back at 2007
Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range
Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
Tripos to Build One of the Leading Informatics-Driven Drug Discovery Laboratories in Europe - - State-of-the-Art Chemical Synthesis Facilities to be Built in Cornwall, England -
5 Leading Multinationals Announce R&D Projects for Ireland - Bristol-Myers Squibb Company, Pfizer Inc., Genzyme Corporation, Xilinx Inc. Citigroup are investing a total of EUR 53.25 million
